Stay updated on Lonca Tesirine + Ibrutinib in Lymphoma Clinical Trial
Sign up to get notified when there's something new on the Lonca Tesirine + Ibrutinib in Lymphoma Clinical Trial page.

Latest updates to the Lonca Tesirine + Ibrutinib in Lymphoma Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedThe change updates the ClinicalTrials.gov page revision/version indicator from v3.5.2 to v3.5.3, reflecting a software or site release rather than an alteration to the study details.SummaryDifference0.0%

- Check27 days agoChange DetectedAdded revision: v3.5.2; removed revision: v3.5.0.SummaryDifference0.0%

- Check55 days agoChange DetectedSite revision updated from v3.4.3 to v3.5.0. No visible changes to study content or page layout are indicated by the screenshots.SummaryDifference0.0%

- Check63 days agoChange DetectedSite revision updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check91 days agoChange DetectedAdded Revision: v3.4.2; removed the government funding lapse notice and the earlier Revision: v3.4.1 from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check98 days agoChange DetectedA site-wide notice about a lapse in government funding and the NIH Clinical Center operating status has been added, and the site revision was updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

Stay in the know with updates to Lonca Tesirine + Ibrutinib in Lymphoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Lonca Tesirine + Ibrutinib in Lymphoma Clinical Trial page.